Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3

P Paul Wheatley Price (The Ottawa Hospital Research Institute/University of Ottawa, Ottawa, ON, Canada) N Nofisat Ismaila (American Society of Clinical Oncology (ASCO), Alexandria, VA, US) A Antonio Calles Blanco (Hospital General Universitario Gregorio Marañón, Madrid, Spain) J Jeremy Cetnar (Knight Cancer Institute, OHSU, Portland, OR, US) T Terri Conneran (KRAS Kickers, San Francisco, CA, US) P Parth A. Desai G Greg Durm (Indiana University Health, Indianapolis, IN, US) H Hidehito Horinouchi (National Cancer Center Hospital, Tokyo, Japan) H Humera Khurshid (Division of Hematology and Oncology Department of Medicine Warren Alpert School of Medicine Brown University Providence Rhode Island USA) S Swati Kulkarni (Windsor Regional Cancer Program/Western University, Windsor, ON, Canada) K Kristen Ashley Marrone (John Hopkins Medical Center, Baltimore, MD, US) K Kirstin Perdrizet (William Osler Health System, Brampton, ON, Canada) L Lyudmila Bazhenova (University of California, San Diego, San Diego, CA, US)

Abstract

This guideline has been updated. This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the online dynamic version for the latest updates. Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix I and Appendix II). Updates are published regularly and can be found on the ASCO Publications website .

Article Details

Volume / Issue Vol. 1, Issue 1
Published August 17, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (13)

P

Paul Wheatley Price

The Ottawa Hospital Research Institute/University of Ottawa, Ottawa, ON, Canada

N

Nofisat Ismaila

American Society of Clinical Oncology (ASCO), Alexandria, VA, US

A

Antonio Calles Blanco

Hospital General Universitario Gregorio Marañón, Madrid, Spain

J

Jeremy Cetnar

Knight Cancer Institute, OHSU, Portland, OR, US

T

Terri Conneran

KRAS Kickers, San Francisco, CA, US

P

Parth A. Desai

G

Greg Durm

Indiana University Health, Indianapolis, IN, US

H

Hidehito Horinouchi

National Cancer Center Hospital, Tokyo, Japan

H

Humera Khurshid

Division of Hematology and Oncology Department of Medicine Warren Alpert School of Medicine Brown University Providence Rhode Island USA

S

Swati Kulkarni

Windsor Regional Cancer Program/Western University, Windsor, ON, Canada

K

Kristen Ashley Marrone

John Hopkins Medical Center, Baltimore, MD, US

K

Kirstin Perdrizet

William Osler Health System, Brampton, ON, Canada

L

Lyudmila Bazhenova

University of California, San Diego, San Diego, CA, US